A multicenter study of shenfu injection on sepsis induced myocardium dysfunction

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039035

Enrollment

Unknown

Registered

2020-10-14

Start date

2020-10-15

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis induced myocardium dysfunction

Interventions

experimental group:Shenfu injection+basic treatment

control group:basic treatment

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of septic shock; 2.Aged 18-85 years, Regardless of gender; 3.Sign informed consent; 4.It conforms to the diagnostic classification standard of "Deficiency of Yang qi".

Exclusion criteria

Exclusion criteria: 1.Patients with acute myocardial infarction; 2.Severe heart failure (grade V cardiac function, or left ventricular ejection fraction 300umol/L, or emergency CRRT; 8.Hepatic insufficiency, total bilirubin >= 100umol/L; 9.Pregnant or lactating women; 10.A mentally or legally disabled person; 11.have participated in other clinical trials in the past three months.

Design outcomes

Primary

Measure	Time frame
Left ventricular size;left ventricular ejection fraction (LVEF);cTnI;?????????;	—

Countries

China

Contacts

Public ContactNi Hai-Bin

Jiangsu Province Hospital on Integration of Chinese and Western Medicine affiliated to Nanjing University of Chinese Medicine

nhb_2002@126.com+86 25-52362019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026